[Congressional Record Volume 169, Number 39 (Wednesday, March 1, 2023)]
[Senate]
[Page S567]
From the Congressional Record Online through the Government Publishing Office [www.gpo.gov]




                         REPORTS OF COMMITTEES

  The following reports of committees were submitted:

       By Mr. PETERS, from the Committee on Homeland Security and 
     Governmental Affairs:
       Special Report entitled ``Activities of the Committee on 
     Homeland Security and Governmental Affairs during the 117th 
     Congress'' (Rept. No. 118-1).
       By Mr. DURBIN, from the Committee on the Judiciary, without 
     amendment:
       S. 79. A bill to amend title 35, United States Code, to 
     establish an interagency task force between the United States 
     Patent and Trademark Office and the Food and Drug 
     Administration for purposes of sharing information and 
     providing technical assistance with respect to patents, and 
     for other purposes.
       By Mr. DURBIN, from the Committee on the Judiciary, with an 
     amendment in the nature of a substitute:
       S. 113. A bill to require the Federal Trade Commission to 
     study the role of intermediaries in the pharmaceutical supply 
     chain and provide Congress with appropriate policy 
     recommendations, and for other purposes.
       S. 142. A bill to prohibit brand name drug companies from 
     compensating generic drug companies to delay the entry of a 
     generic drug into the market, and to prohibit biological 
     product manufacturers from compensating biosimilar and 
     interchangeable companies to delay the entry of biosimilar 
     biological products and interchangeable biological products.
       S. 148. A bill to enable to Federal Trade Commission to 
     deter filing of sham citizen petitions to cover an attempt to 
     interfere with approval of a competing generic drug or 
     biosimilar, to foster competition, and facilitate the 
     efficient review of petitions filed in good faith to raise 
     legitimate public health concerns, and for other purposes.
       By Mr. DURBIN, from the Committee on the Judiciary, without 
     amendment:
       S. 150. A bill to amend the Federal Trade Commission Act to 
     prohibit product hopping, and for other purposes.

                          ____________________